Sjögrens syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB

M. Sisto, S. Lisi, D. D. Lofrumento, M. D'amore, M. A. Frassanito, D. Ribatti

Research output: Contribution to journalArticle

Abstract

We explore the involvement of tumor necrosis factor α (TNF-α)-converting enzyme (TACE) in vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR2) (VEGF-A/VEGFR2)-mediated angiogenesis in Sjögrens syndrome (SS), one of the most common autoimmune rheumatic diseases. To test the hypothesis that SS autoantibodies (Abs) regulate VEGF-A/VEGFR2 expression by a TACE-dependent nuclear factor-B (NF-κB) activation pathway, their effects on the expression and activation of the VEGF-A/TACE/VEGFR2/NF-κB pathway were determined in human salivary gland epithelial cells (SGEC). An enhanced angiogenesis in SS salivary gland biopsies was observed, associated with an increased VEGF-A expression and activation of VEGF-A/VEGFR2 signaling. Human cytokine array analysis of the pro-inflammatory and pro-angiogenic protein response in SGEC treated with SS Abs revealed an overexpression of multiple pro-angiogenic factors. TACE RNA knockdown, the use of anti-VEGF-A monoclonal antibody and the inhibition of NF-κB activity significantly abrogated the release of pro-angiogenic factors, demonstrating that VEGF-A/TACE/VEGFR2/NF-κB axis dysfunction may be contributory to pathogenesis and exacerbation of this autoimmune condition.

Original languageEnglish
Pages (from-to)411-420
Number of pages10
JournalGenes and Immunity
Volume13
Issue number5
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Pathologic Neovascularization
Vascular Endothelial Growth Factor Receptor
Vascular Endothelial Growth Factor A
Salivary Glands
Angiogenesis Inducing Agents
Autoantibodies
Angiogenic Proteins
Epithelial Cells
Vascular Endothelial Growth Factor Receptor-2
Rheumatic Diseases
Autoimmune Diseases
Tumor Necrosis Factor-alpha
Monoclonal Antibodies
RNA
Cytokines
Biopsy

Keywords

  • NF-κB
  • Sjögren's syndrome
  • TACE
  • VEGF-A
  • VEGFR2

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

Sjögrens syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. / Sisto, M.; Lisi, S.; Lofrumento, D. D.; D'amore, M.; Frassanito, M. A.; Ribatti, D.

In: Genes and Immunity, Vol. 13, No. 5, 07.2012, p. 411-420.

Research output: Contribution to journalArticle

Sisto, M. ; Lisi, S. ; Lofrumento, D. D. ; D'amore, M. ; Frassanito, M. A. ; Ribatti, D. / Sjögrens syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. In: Genes and Immunity. 2012 ; Vol. 13, No. 5. pp. 411-420.
@article{64bda20897884b3383f910cd76fff23e,
title = "Sj{\"o}grens syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB",
abstract = "We explore the involvement of tumor necrosis factor α (TNF-α)-converting enzyme (TACE) in vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR2) (VEGF-A/VEGFR2)-mediated angiogenesis in Sj{\"o}grens syndrome (SS), one of the most common autoimmune rheumatic diseases. To test the hypothesis that SS autoantibodies (Abs) regulate VEGF-A/VEGFR2 expression by a TACE-dependent nuclear factor-B (NF-κB) activation pathway, their effects on the expression and activation of the VEGF-A/TACE/VEGFR2/NF-κB pathway were determined in human salivary gland epithelial cells (SGEC). An enhanced angiogenesis in SS salivary gland biopsies was observed, associated with an increased VEGF-A expression and activation of VEGF-A/VEGFR2 signaling. Human cytokine array analysis of the pro-inflammatory and pro-angiogenic protein response in SGEC treated with SS Abs revealed an overexpression of multiple pro-angiogenic factors. TACE RNA knockdown, the use of anti-VEGF-A monoclonal antibody and the inhibition of NF-κB activity significantly abrogated the release of pro-angiogenic factors, demonstrating that VEGF-A/TACE/VEGFR2/NF-κB axis dysfunction may be contributory to pathogenesis and exacerbation of this autoimmune condition.",
keywords = "NF-κB, Sj{\"o}gren's syndrome, TACE, VEGF-A, VEGFR2",
author = "M. Sisto and S. Lisi and Lofrumento, {D. D.} and M. D'amore and Frassanito, {M. A.} and D. Ribatti",
year = "2012",
month = "7",
doi = "10.1038/gene.2012.9",
language = "English",
volume = "13",
pages = "411--420",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Sjögrens syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB

AU - Sisto, M.

AU - Lisi, S.

AU - Lofrumento, D. D.

AU - D'amore, M.

AU - Frassanito, M. A.

AU - Ribatti, D.

PY - 2012/7

Y1 - 2012/7

N2 - We explore the involvement of tumor necrosis factor α (TNF-α)-converting enzyme (TACE) in vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR2) (VEGF-A/VEGFR2)-mediated angiogenesis in Sjögrens syndrome (SS), one of the most common autoimmune rheumatic diseases. To test the hypothesis that SS autoantibodies (Abs) regulate VEGF-A/VEGFR2 expression by a TACE-dependent nuclear factor-B (NF-κB) activation pathway, their effects on the expression and activation of the VEGF-A/TACE/VEGFR2/NF-κB pathway were determined in human salivary gland epithelial cells (SGEC). An enhanced angiogenesis in SS salivary gland biopsies was observed, associated with an increased VEGF-A expression and activation of VEGF-A/VEGFR2 signaling. Human cytokine array analysis of the pro-inflammatory and pro-angiogenic protein response in SGEC treated with SS Abs revealed an overexpression of multiple pro-angiogenic factors. TACE RNA knockdown, the use of anti-VEGF-A monoclonal antibody and the inhibition of NF-κB activity significantly abrogated the release of pro-angiogenic factors, demonstrating that VEGF-A/TACE/VEGFR2/NF-κB axis dysfunction may be contributory to pathogenesis and exacerbation of this autoimmune condition.

AB - We explore the involvement of tumor necrosis factor α (TNF-α)-converting enzyme (TACE) in vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR2) (VEGF-A/VEGFR2)-mediated angiogenesis in Sjögrens syndrome (SS), one of the most common autoimmune rheumatic diseases. To test the hypothesis that SS autoantibodies (Abs) regulate VEGF-A/VEGFR2 expression by a TACE-dependent nuclear factor-B (NF-κB) activation pathway, their effects on the expression and activation of the VEGF-A/TACE/VEGFR2/NF-κB pathway were determined in human salivary gland epithelial cells (SGEC). An enhanced angiogenesis in SS salivary gland biopsies was observed, associated with an increased VEGF-A expression and activation of VEGF-A/VEGFR2 signaling. Human cytokine array analysis of the pro-inflammatory and pro-angiogenic protein response in SGEC treated with SS Abs revealed an overexpression of multiple pro-angiogenic factors. TACE RNA knockdown, the use of anti-VEGF-A monoclonal antibody and the inhibition of NF-κB activity significantly abrogated the release of pro-angiogenic factors, demonstrating that VEGF-A/TACE/VEGFR2/NF-κB axis dysfunction may be contributory to pathogenesis and exacerbation of this autoimmune condition.

KW - NF-κB

KW - Sjögren's syndrome

KW - TACE

KW - VEGF-A

KW - VEGFR2

UR - http://www.scopus.com/inward/record.url?scp=84864146262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864146262&partnerID=8YFLogxK

U2 - 10.1038/gene.2012.9

DO - 10.1038/gene.2012.9

M3 - Article

C2 - 22513453

AN - SCOPUS:84864146262

VL - 13

SP - 411

EP - 420

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 5

ER -